{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T13:10:22Z","timestamp":1773925822195,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,11,26]],"date-time":"2014-11-26T00:00:00Z","timestamp":1416960000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s10753-014-0067-z","type":"journal-article","created":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T12:03:32Z","timestamp":1417435412000},"page":"1028-1035","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Artesunate Ameliorates Functional Limitations in Freund\u2019s Complete Adjuvant-Induced Monoarthritis in Rat by Maintaining Oxidative Homeostasis and Inhibiting COX-2 Expression"],"prefix":"10.1007","volume":"38","author":[{"given":"B.","family":"Guruprasad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyanka","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tenzin","family":"Choedon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijay L.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,11,26]]},"reference":[{"key":"67_CR1","doi-asserted-by":"crossref","first-page":"i61","DOI":"10.1136\/ard.2009.119404","volume":"69","author":"SE Gabriel","year":"2010","unstructured":"Gabriel, S.E. 2010. Heart disease and rheumatoid arthritis: understanding the risks. Ann Rheum Dis 69: i61\u2013i64.","journal-title":"Ann Rheum Dis"},{"key":"67_CR2","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1002\/1529-0131(200112)44:12<2746::AID-ART461>3.0.CO;2-Z","volume":"44","author":"JB Wong","year":"2001","unstructured":"Wong, J.B., D.R. Ramey, and G. Singh. 2001. Long-term morbidity, mortality, and economics of rheumatoid arthritis. Arthritis Rheum 44: 2746\u20132749.","journal-title":"Arthritis Rheum"},{"key":"67_CR3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/jlb.59.1.6","volume":"59","author":"SL Kunkel","year":"1996","unstructured":"Kunkel, S.L., N. Lukacs, T. Kasama, and R.M. Strieter. 1996. The role of chemokines in inflammatory joint disease. J Leukoc Biol 59: 6\u201312.","journal-title":"J Leukoc Biol"},{"key":"67_CR4","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/art.21562","volume":"54","author":"JM Hootman","year":"2006","unstructured":"Hootman, J.M., and C.G. Helmick. 2006. Projections of US prevalence of arthritis and associated activity limitations. Arthritis Rheum 54: 226\u2013229.","journal-title":"Arthritis Rheum"},{"key":"67_CR5","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/ar3910","volume":"15","author":"LJ Crofford","year":"2013","unstructured":"Crofford, L.J. 2013. Use of NSAIDs in treating patients with arthritis. Arthritis Res Ther 15: S2.","journal-title":"Arthritis Res Ther"},{"key":"67_CR6","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0049-0172(97)80046-7","volume":"26","author":"JR Vane","year":"1997","unstructured":"Vane, J.R., and R.M. Botting. 1997. Mechanism of action of aspirin-like drugs. Semin Arthritis Rheum 26: 2\u201310.","journal-title":"Semin Arthritis Rheum"},{"key":"67_CR7","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/ard.2010.132134","volume":"70","author":"C Salliot","year":"2011","unstructured":"Salliot, C., A. Finckh, W. Katchamart, Y. Lu, Y. Sun, C. Bombardier, and E. Keystone. 2011. Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysis. Ann Rheum Dis 70: 266\u2013271.","journal-title":"Ann Rheum Dis"},{"key":"67_CR8","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1185\/030079904X12681","volume":"20","author":"DJ Watson","year":"2004","unstructured":"Watson, D.J., J.A. Bolognese, C. Yu, D. Krupa, and S. Curtis. 2004. Use of gastroprotective agents and discontinuations due to dyspepsia with the selective cyclooxygenase-2 inhibitor etoricoxib compared with non-selective NSAIDs. Curr Med Res Opin 20: 1899\u20131908.","journal-title":"Curr Med Res Opin"},{"key":"67_CR9","doi-asserted-by":"crossref","unstructured":"Graziose, R., M.A. Lila, and I. Raskin. 2010. Merging traditional Chinese medicine with modern drug discovery technologies to find novel drugs and functional food. Curr Drug Discov Technol 7: 2\u201312.","DOI":"10.2174\/157016310791162767"},{"key":"67_CR10","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/cmi.2009.58","volume":"6","author":"O Jin","year":"2009","unstructured":"Jin, O., H. Zhang, Z. Gu, S. Zhao, T. Xu, K. Zhou, B. Jiang, J. Wang, X. Zeng, and L. Sun. 2009. A pilot study of the therapeutic efficacy and mechanism of artesunate in the MRL\/lpr murine model of systemic lupus erythematosus. Cell Mol Immunol 6: 461\u2013467.","journal-title":"Cell Mol Immunol"},{"key":"67_CR11","doi-asserted-by":"crossref","unstructured":"Li, B., R. Zhang, J. Li, L. Zhang, G. Ding, P. Luo, S. He, Y. Dong, W. Jiang, Y. Lu, H. Cao, J. Zhang, and H. Zhou. 2008. Antimalarial artesunate protects sepsis model mice against heat-killed Escherichia coli challenge by decreasing TLR4, TLR9 mRNA expressions and transcription factor NF-kappa B activation. Int Immunopharmacol 8: 379\u2013389.","DOI":"10.1016\/j.intimp.2007.10.024"},{"key":"67_CR12","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.intimp.2009.12.006","volume":"10","author":"B Li","year":"2010","unstructured":"Li, B., J. Li, X. Pan, G. Ding, H. Cao, W. Jiang, J. Zheng, and H. Zhou. 2010. Artesunate protects sepsis model mice challenged with Staphylococcus aureus by decreasing TNF- alpha release via inhibition of TLR2 and Nod2 mRNA expressions and transcription factor NF-kappaB activation. Int Immunopharmacol 10: 344\u2013350.","journal-title":"Int Immunopharmacol"},{"key":"67_CR13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00296-009-1218-7","volume":"31","author":"Y He","year":"2011","unstructured":"He, Y., J. Fan, H. Lin, X. Yang, Y. Ye, L. Liang, Z. Zhan, X. Dong, L. Sun, and H. Xu. 2011. The anti-malaria agent artesunate inhibits expression of vascular endothelial growth factor and hypoxia-inducible factor-1\u03b1 in human rheumatoid arthritis fibroblast-like synoviocyte. Rheumatol Int 31: 53\u201360.","journal-title":"Rheumatol Int"},{"key":"67_CR14","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.trsl.2012.06.001","volume":"161","author":"Y Li","year":"2013","unstructured":"Li, Y., S. Wang, Y. Wang, C. Zhou, G. Chen, W. Shen, C. Li, W. Lin, S. Lin, H. Huang, P. Liu, and X. Shen. 2013. Inhibitory effect of the antimalarial agent artesunate on collagen-induced arthritis in rats through nuclear factor kappa B and mitogen-activated protein kinase signaling pathway. Transl Res 161: 89\u201398.","journal-title":"Transl Res"},{"key":"67_CR15","unstructured":"Kumar, V.L., B. Guruprasad, and P. Chaudhary. 2014. Antimalarial drug artesunate affords protection against carrageenan induced acute inflammation in rat. Biocell (in press)."},{"key":"67_CR16","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/j.1476-5381.2009.00586.x","volume":"159","author":"FF Lam","year":"2010","unstructured":"Lam, F.F., and E.S. Ng. 2010. Substance P and glutamate receptor antagonists improve the anti-arthritic actions of dexamethasone in rats. Br J Pharmacol 159: 958\u2013969.","journal-title":"Br J Pharmacol"},{"key":"67_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7243\/2054-720X-1-1","volume":"1","author":"VL Kumar","year":"2014","unstructured":"Kumar, V.L., P. Chaudhary, R.M. Oliveira, and M.V. Ramos. 2014. Calotropis procera latex proteins ameliorate functional limitations associated with adjuvant induced inflammation in rat. Musculoskelet Biol 1: 1.","journal-title":"Musculoskelet Biol"},{"key":"67_CR18","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0304-3959(81)90193-7","volume":"10","author":"M Castro Costa De","year":"1981","unstructured":"De Castro Costa, M., P. De Sutter, J. Gybels, and J. Van Hees. 1981. Adjuvant-induced arthritis in rats: a possible animal model of chronic pain. Pain 10: 173\u2013185.","journal-title":"Pain"},{"key":"67_CR19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0304-3959(92)90133-V","volume":"48","author":"SH Butler","year":"1992","unstructured":"Butler, S.H., F. Godefroy, J.M. Besson, and J. Weil-Fugazza. 1992. A limited arthritic model for chronic pain studies in the rat. Pain 48: 73\u201381.","journal-title":"Pain"},{"key":"67_CR20","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.phrs.2009.11.006","volume":"61","author":"VD Wahane","year":"2010","unstructured":"Wahane, V.D., and V.L. Kumar. 2010. Atorvastatin ameliorates inflammatory hyperalgesia in rat model of monoarticular arthritis. Pharmacol Res 61: 329\u2013333.","journal-title":"Pharmacol Res"},{"key":"67_CR21","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0024-3205(00)00625-1","volume":"67","author":"Y Wang","year":"2000","unstructured":"Wang, Y., C. Huang, Y. Cao, and J.S. Han. 2000. Repeated administration of low dose ketamine for the treatment of monoarthritic pain in the rat. Life Sci 67: 261\u2013267.","journal-title":"Life Sci"},{"key":"67_CR22","doi-asserted-by":"crossref","unstructured":"Bradley, P.P., D.A. Preibat, R.D. Christensen, and G. Rothstein. 1982. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 78: 206\u2013209.","DOI":"10.1111\/1523-1747.ep12506462"},{"key":"67_CR23","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1161\/hc3201.092284","volume":"104","author":"Q Feng","year":"2001","unstructured":"Feng, Q., X. Lu, D.L. Jones, J. Shen, and J.M. Arnold. 2001. Increased inducible nitric oxide synthase expression contributes to myocardial dysfunction and higher mortality after myocardial infarction in mice. Circulation 104: 700\u2013704.","journal-title":"Circulation"},{"key":"67_CR24","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","volume":"82","author":"GL Ellman","year":"1959","unstructured":"Ellman, G.L. 1959. Tissue sulfhydryl groups. Arch Biochem Biophys 82: 70\u201377.","journal-title":"Arch Biochem Biophys"},{"key":"67_CR25","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"H Ohkawa","year":"1979","unstructured":"Ohkawa, H., N. Ohishi, and K. Yagi. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95: 351\u2013358.","journal-title":"Anal Biochem"},{"key":"67_CR26","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bcp.2006.08.027","volume":"73","author":"N Lin","year":"2007","unstructured":"Lin, N., C. Liu, C. Xiao, H. Jia, K. Imada, H. Wu, and A. Ito. 2007. Triptolide, diterpenoid triepoxide, suppresses inflammation and cartilage destruction in collagen-induced arthritis mice. Biochem Pharmacol 73: 136\u2013146.","journal-title":"Biochem Pharmacol"},{"key":"67_CR27","doi-asserted-by":"crossref","first-page":"R35","DOI":"10.1186\/ar2640","volume":"11","author":"JC Grauw de","year":"2009","unstructured":"de Grauw, J.C., C.H.A. van de Lest, and P.R. van Weeren. 2009. Inflammatory mediators and cartilage biomarkers in synovial fluid after a single inflammatory insult: a longitudinal experimental study. Arthritis Res Ther 11: R35.","journal-title":"Arthritis Res Ther"},{"key":"67_CR28","doi-asserted-by":"crossref","first-page":"e75031","DOI":"10.1371\/journal.pone.0075031","volume":"8","author":"J Kroon","year":"2013","unstructured":"Kroon, J., S. Tol, S. van Amstel, J.A. Elias, and M. Fernandez- Borja. 2013. The small GTPase RhoB regulates TNF\u03b1 signaling in endothelial cells. PLoS One 8: e75031.","journal-title":"PLoS One"},{"key":"67_CR29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1742-2094-7-27","volume":"7","author":"L Leung","year":"2010","unstructured":"Leung, L., and C.M. Cahill. 2010. TNF-alpha and neuropathic pain-a review. J Neuroinflammation 7: 27.","journal-title":"J Neuroinflammation"},{"key":"67_CR30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1023\/A:1019927616000","volume":"238","author":"S Nakao","year":"2002","unstructured":"Nakao, S., Y. Ogtata, E. Shimizu, M. Yamazaki, S. Furuyama, and H. Sugiya. 2002. Tumor necrosis factor alpha (TNF-alpha)-induced prostaglandin E2 release is mediated by the activation of cyclooxygenase-2 (COX-2) transcription via NFkappaB in human gingival fibroblasts. Mol Cell Biochem 238: 11\u201318.","journal-title":"Mol Cell Biochem"},{"key":"67_CR31","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1096\/fasebj.12.12.1063","volume":"12","author":"RN Dubois","year":"1998","unstructured":"Dubois, R.N., S.B. Abramson, L. Crofford, R.A. Gupta, L.S. Simon, L.B. Van De Putte, and P.E. Lipsky. 1998. Cyclooxygenase in biology and disease. FASEB J 12: 1063\u20131073.","journal-title":"FASEB J"},{"key":"67_CR32","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pain.2009.08.013","volume":"148","author":"A Telleria-Diaz","year":"2010","unstructured":"Telleria-Diaz, A., M. Schmidt, S. Kreusch, A.K. Neubert, F. Schache, E. Vazquez, H. Vanegas, H.G. Schaible, and A. Ebersberger. 2010. Spinal antinociceptive effects of cyclooxygenase inhibition during inflammation: Involvement of prostaglandins and endocannabinoids. Pain 148: 26\u201335.","journal-title":"Pain"},{"key":"67_CR33","doi-asserted-by":"crossref","first-page":"11703","DOI":"10.1074\/jbc.270.20.11703","volume":"270","author":"A Ben-Baruch","year":"1995","unstructured":"Ben-Baruch, A., D.F. Michiel, and J.J. Oppenheim. 1995. Signals and receptors involved in recruitment of inflammatory cells. J Biol Chem 270: 11703\u201311706.","journal-title":"J Biol Chem"},{"key":"67_CR34","doi-asserted-by":"crossref","unstructured":"Lemos, H.P., R. Grespan, S.M. Vieira, T.M. Cunha, W.A. Verri Jr., K.S. Fernandes, F.O. Souto, I.B. McInnes, S.H. Ferreira, F.Y. Liew, and F.Q. Cunha. 2009. Prostaglandin mediates IL-23\/IL-17-induced neutrophil migration in inflammation by inhibiting IL-12 and IFNgamma production. Proc Natl Acad Sci U S A 106: 5954\u20135959.","DOI":"10.1073\/pnas.0812782106"},{"key":"67_CR35","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1139\/y11-055","volume":"89","author":"C Ziskoven","year":"2011","unstructured":"Ziskoven, C., M. J\u00e4ger, J. Kircher, T. Patzer, W. Bloch, K. Brixius, and R. Krauspe. 2011. Physiology and pathophysiology of nitrosative and oxidative stress in osteoarthritic joint destruction. Can J Physiol Pharmacol 89: 455\u2013466.","journal-title":"Can J Physiol Pharmacol"},{"key":"67_CR36","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/ar1447","volume":"6","author":"CA Hitchon","year":"2004","unstructured":"Hitchon, C.A., and H.S. El-Gabalawy. 2004. Oxidation in rheumatoid arthritis. Arthritis Res Ther 6: 265\u2013278.","journal-title":"Arthritis Res Ther"},{"key":"67_CR37","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0928-4680(00)00053-5","volume":"7","author":"K Kannan","year":"2000","unstructured":"Kannan, K., and S.K. Jain. 2000. Oxidative stress and apoptosis. Pathophysiology 7: 153\u2013163.","journal-title":"Pathophysiology"},{"key":"67_CR38","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1056\/NEJM199312303292706","volume":"329","author":"S Moncada","year":"1993","unstructured":"Moncada, S., and A. Higgs. 1993. The L-arginine-nitric oxide pathway. N Engl J Med 329: 2002\u20132012.","journal-title":"N Engl J Med"},{"key":"67_CR39","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1476-5381.1995.tb13330.x","volume":"114","author":"D Salvemini","year":"1995","unstructured":"Salvemini, D., S.L. Settle, J.L. Masferrer, K. Seibert, M.G. Currie, and P. Needleman. 1995. Regulation of prostaglandin production by nitric oxide; an in vivo analysis. Br J Pharmacol 114: 1171\u20131178.","journal-title":"Br J Pharmacol"},{"key":"67_CR40","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/ard.61.1.76","volume":"61","author":"Y Ersoy","year":"2002","unstructured":"Ersoy, Y., E. Ozerol, O. Baysal, I. Temel, R.S. MacWalter, U. Meral, and Z.E. Altay. 2002. Serum nitrate and nitrite levels in patients with rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis. Ann Rheum Dis 61: 76\u201378.","journal-title":"Ann Rheum Dis"},{"key":"67_CR41","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1046\/j.1365-2249.1998.00438.x","volume":"111","author":"YH Yang","year":"1998","unstructured":"Yang, Y.H., P. Hutchinson, L.L. Santos, and E.F. Morand. 1998. Glucocorticoid inhibition of adjuvant arthritis synovial macrophage nitric oxide production: role of lipocortin 1. Clin Exp Immunol 111: 117\u2013122.","journal-title":"Clin Exp Immunol"},{"key":"67_CR42","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1093\/rheumatology\/keq045","volume":"49","author":"HL Wright","year":"2010","unstructured":"Wright, H.L., R.J. Moots, R.C. Bucknall, and S.W. Edwards. 2010. Neutrophil function in inflammation and inflammatory diseases. Rheumatology 49: 1618\u20131631.","journal-title":"Rheumatology"},{"key":"67_CR43","doi-asserted-by":"crossref","unstructured":"Ad\u00e1n, N., J. Guzm\u00e1n-Morales, M.G. Ledesma-Colunga, S.I. Perales-Canales, A. Quintanar-St\u00e9phano, F. L\u00f3pez-Barrera, I. Mendez, B. Moreno-Carranza, J. Triebel, N. Binart, G. Martinez de la Escalera, S. Thebault, and C. Clapp. 2013. Prolactin promotes cartilage survival and attenuates inflammation in inflammatory arthritis. J Clin Invest 123: 3902\u20133913.","DOI":"10.1172\/JCI69485"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-014-0067-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10753-014-0067-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-014-0067-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,18]],"date-time":"2019-08-18T00:17:32Z","timestamp":1566087452000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10753-014-0067-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,26]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["67"],"URL":"https:\/\/doi.org\/10.1007\/s10753-014-0067-z","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,26]]}}}